{
    "clinical_study": {
        "@rank": "127582", 
        "arm_group": [
            {
                "arm_group_label": "Training cohort", 
                "description": "This cohort is a prospective cohort to develop a risk prediction model. This cohort include patients who underwent staging operation or debulking operation for epithelial ovarian cancer and are planned to receive ajuvant chemotherapy with paclitaxel/carboplatin up to 6 cycles."
            }, 
            {
                "arm_group_label": "Validation cohort", 
                "description": "This is a retrospective cohort for validation of a risk prediction model developed using training cohort.\nThis is consisted with 600 patients with epithelial ovarian cancer who received adjuvant chemotherapy with paclitaxel/carboplatin after staging operation or debulking operation."
            }
        ], 
        "brief_summary": {
            "textblock": "To develop a robust prediction model to predict the occurrence of grade 3-4 neutropenia\n      induced by adjuvant paclitaxel/carboplatin chemotherapy in patients with epithelial ovarian\n      cancer and to validate this model."
        }, 
        "brief_title": "Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer", 
        "condition": "Epithelial Ovarian Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Neutropenia", 
                "Ovarian Neoplasms", 
                "Neoplasms, Glandular and Epithelial"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with FIGO stage I-IV epithelial ovarian cancer after staging or debulking\n             surgery\n\n          -  Patients who is planned to receive (prospective cohort) ro who received\n             (retrospective cohort) adjuvant chemotherapy with paclitaxel and carboplatin\n\n          -  Patients who have signed approved informed consent\n\n        Exclusion Criteria:\n\n          -  Uncontrolled medical disease\n\n          -  Active infectious disease\n\n          -  Previous pelvic radiation therapy\n\n          -  Previous chemotherapy (prospective cohort)\n\n          -  Patients with disease which can cause neutropenia\n\n          -  Patients who will receive other targeted therapy or immunotherapy during adjuvant\n             therapy (prospective cohort).\n\n          -  Pregnant or lactating woman"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Training cohort (prospective cohort): Patients with epithelial ovarian cancer who\n        underwent staging operation or debulking surgery at university hospital and who are\n        planned to receive adjuvant chemotherapy with paclitaxel and carboplatin.\n\n        Validation cohort (retrospective cohort): Patients with epithelial ovarian cancer who\n        received adjuvant chemotherapy with paclitaxel and carboplatin after staging operation or\n        debulking operation."
            }
        }, 
        "enrollment": {
            "#text": "750", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01680575", 
            "org_study_id": "NEPACA-OVCA"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Carboplatin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Neutropenia", 
            "Paclitaxel", 
            "Carboplatin", 
            "Epithelial ovarian cancer"
        ], 
        "lastchanged_date": "September 8, 2012", 
        "location": {
            "contact": {
                "last_name": "Jeong-Yeol Park, M.D., Ph.D."
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "2", 
        "official_title": "Development of a Risk Model Predicting Chemotherapy-induced Grade 3-4 Neutropenia by Paclitaxel/Carboplatin in Epithelial Ovarian Cancer: Prospective Observational Study for Model Development and Retrospective Study for Validation of Developed Model", 
        "overall_contact": {
            "email": "catgut1-0@hanmail.net", 
            "last_name": "Jeong-Yeol Park, M.D., Ph.D.", 
            "phone": "82-2-3010-3646"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Jeong-Yeol Park, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Asan Medical Center Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Risk prediction model for grade 3-4 chemotherapy induced neutropenia", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01680575"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Jeong-Yeol Park", 
            "investigator_title": "Clinical Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The association between mannose-binding lectin 2 gene SNP and neutropenia", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}